CreatorsPublishersAdvertisers
View more in
Health

Another Patient Dies Following Treatment with Astellas' Experimental Gene Therapy

biospace.com
 2021-09-14

Cover picture for the articleA patient treated with Astellas Pharma’s experimental gene therapy for patients with X-linked Myotubular Myopathy (XLMTM) has died after reports of a serious adverse event following treatment with AT132 earlier this month. The patient’s death marks the fourth during clinical trials over the past two years. The patient, who...

www.biospace.com

Comments / 0

Comments / 0